vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $13.4M, roughly 1.6× Outdoor Holding Co). Outdoor Holding Co runs the higher net margin — 16.7% vs -373.3%, a 390.0% gap on every dollar of revenue. Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
AUTL vs POWW — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $13.4M |
| Net Profit | $-79.1M | $2.2M |
| Gross Margin | — | 87.1% |
| Operating Margin | -337.9% | 14.7% |
| Net Margin | -373.3% | 16.7% |
| Revenue YoY | — | -54.1% |
| Net Profit YoY | 3.6% | 108.5% |
| EPS (diluted) | $-0.30 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.4M | ||
| Q3 25 | $21.2M | $12.0M | ||
| Q2 25 | $20.9M | $11.9M | ||
| Q1 25 | $9.0M | $12.6M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | $0 | $12.0M | ||
| Q2 24 | $0 | $12.3M | ||
| Q1 24 | $10.1M | $-50.7M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | $-79.1M | $1.4M | ||
| Q2 25 | $-47.9M | $-6.5M | ||
| Q1 25 | $-70.2M | $-77.5M | ||
| Q4 24 | — | $-26.1M | ||
| Q3 24 | $-82.1M | $-12.4M | ||
| Q2 24 | $-58.3M | $-14.8M | ||
| Q1 24 | $-52.7M | $-5.2M |
| Q4 25 | — | 87.1% | ||
| Q3 25 | — | 87.1% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 87.5% | ||
| Q4 24 | — | 87.4% | ||
| Q3 24 | — | 86.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 14.7% | ||
| Q3 25 | -337.9% | 5.9% | ||
| Q2 25 | -292.6% | -50.7% | ||
| Q1 25 | -726.3% | -213.6% | ||
| Q4 24 | — | -163.8% | ||
| Q3 24 | — | -50.3% | ||
| Q2 24 | — | -50.8% | ||
| Q1 24 | -384.1% | — |
| Q4 25 | — | 16.7% | ||
| Q3 25 | -373.3% | 11.7% | ||
| Q2 25 | -229.0% | -54.5% | ||
| Q1 25 | -781.1% | -614.5% | ||
| Q4 24 | — | -208.7% | ||
| Q3 24 | — | -103.7% | ||
| Q2 24 | — | -120.2% | ||
| Q1 24 | -522.1% | 10.3% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.30 | $0.01 | ||
| Q2 25 | $-0.18 | $-0.06 | ||
| Q1 25 | $-0.26 | $-0.67 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-0.31 | $-0.11 | ||
| Q2 24 | $-0.22 | $-0.13 | ||
| Q1 24 | $-0.24 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $69.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $237.3M |
| Total Assets | $661.9M | $271.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $69.9M | ||
| Q3 25 | $86.1M | $65.7M | ||
| Q2 25 | $123.8M | $63.4M | ||
| Q1 25 | $95.8M | $30.2M | ||
| Q4 24 | — | $31.9M | ||
| Q3 24 | $657.1M | $33.5M | ||
| Q2 24 | $705.9M | $50.8M | ||
| Q1 24 | $758.5M | $55.6M |
| Q4 25 | — | $237.3M | ||
| Q3 25 | $265.5M | $235.4M | ||
| Q2 25 | $346.5M | $222.5M | ||
| Q1 25 | $371.1M | $222.0M | ||
| Q4 24 | — | $299.6M | ||
| Q3 24 | $477.0M | $325.6M | ||
| Q2 24 | $527.8M | $342.5M | ||
| Q1 24 | $582.0M | $358.0M |
| Q4 25 | — | $271.7M | ||
| Q3 25 | $661.9M | $270.3M | ||
| Q2 25 | $721.0M | $269.5M | ||
| Q1 25 | $746.3M | $297.3M | ||
| Q4 24 | — | $355.4M | ||
| Q3 24 | $827.5M | $368.9M | ||
| Q2 24 | $853.6M | $398.6M | ||
| Q1 24 | $901.4M | $403.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $5.7M |
| Free Cash FlowOCF − Capex | $-72.3M | $5.0M |
| FCF MarginFCF / Revenue | -341.2% | 37.6% |
| Capex IntensityCapex / Revenue | 20.8% | 4.8% |
| Cash ConversionOCF / Net Profit | — | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-2.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-67.9M | $3.2M | ||
| Q2 25 | $-72.8M | $-6.7M | ||
| Q1 25 | $-75.6M | $-1.5M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-76.7M | $-9.3M | ||
| Q2 24 | $-51.1M | $-547.5K | ||
| Q1 24 | $-40.5M | $4.3M |
| Q4 25 | — | $5.0M | ||
| Q3 25 | $-72.3M | $2.5M | ||
| Q2 25 | $-80.1M | $-7.6M | ||
| Q1 25 | $-83.8M | $-2.3M | ||
| Q4 24 | — | $720.3K | ||
| Q3 24 | $-86.3M | $-10.6M | ||
| Q2 24 | $-51.9M | $-1.3M | ||
| Q1 24 | $-41.0M | $1.4M |
| Q4 25 | — | 37.6% | ||
| Q3 25 | -341.2% | 21.0% | ||
| Q2 25 | -382.6% | -63.8% | ||
| Q1 25 | -933.1% | -18.6% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | -88.3% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | -406.8% | -2.8% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | 20.8% | 5.8% | ||
| Q2 25 | 34.8% | 7.5% | ||
| Q1 25 | 91.8% | 6.5% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.4% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | 5.3% | -5.7% |
| Q4 25 | — | 2.55× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
